Urinary kallikrein excretion and plasma atrial natriuretic peptide in human salt-sensitive hypertension. 1993

C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
La Sapienza University, Andrea Cesalpino Foundation, Rome, Italy.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017673 Sodium Chloride, Dietary Sodium chloride used in foods. Dietary Sodium Chloride,Table Salt,Chloride, Dietary Sodium,Salt, Table

Related Publications

C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
February 1995, Science (New York, N.Y.),
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
March 1991, American journal of hypertension,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
September 1989, European journal of pharmacology,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
September 1996, Hypertension (Dallas, Tex. : 1979),
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
November 1971, Lancet (London, England),
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
December 1978, Agents and actions,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
January 1978, Endocrine research communications,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
November 1997, Polskie Archiwum Medycyny Wewnetrznej,
C Ferri, and C Bellini, and A Carlomagno, and R Baldoncini, and L De Siati, and A Perrone, and A Santucci, and F Balsano
December 2020, Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria,
Copied contents to your clipboard!